Suzanne R. Burstein
NeuroGenetic Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Amyotrophic Lateral Sclerosis Research, Mitochondrial Function and Pathology, Neurogenesis and neuroplasticity mechanisms, Pluripotent Stem Cells Research, Stress Responses and Cortisol
Most-Cited Works
- → CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes(2020)217 cited
- → ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response(2019)123 cited
- → Effects of Cyclic Adenosine Monophosphate and Melanocyte-Stimulating Hormone on Frog Skin In Vitro(1965)121 cited
- → In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions(2017)119 cited
- → Abnormal Intracellular Calcium Signaling and SNARE-Dependent Exocytosis Contributes to SOD1G93A Astrocyte-Mediated Toxicity in Amyotrophic Lateral Sclerosis(2014)87 cited
- → Sex specific activation of the ERα axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS(2017)66 cited
- → Stress differentially alters mu opioid receptor density and trafficking in parvalbumin‐containing interneurons in the female and male rat hippocampus(2013)60 cited
- → Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results(2024)52 cited
- → Estrogen receptor beta modulates permeability transition in brain mitochondria(2018)50 cited
- → Induced Synthesis of Oestrogens by Glia in the Songbird Brain(2013)40 cited